Suppl data.xlsx (15.41 kB)
Download fileSupplementary Material. Atezolizumab with bevacizumab, PTX and CBDCA was effective for patients with SMARCA4-deficient thoracic sarcoma
dataset
posted on 2021-05-25, 07:59 authored by Hayato Kawachi, Kei Kunimasa, Yoji Kukita, Harumi Nakamura, Keiichiro Honma, Takahisa Kawamura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Yu Mizote, Takashi Akazawa, Hideaki Tahara, Toru KumagaiSupplementary Table 1
– Mutation profile of patients in Case 1, Case 2, and Case 3
